Fleurence, Rachael L.; Iglesias, Cynthia P.; Johnson, … - In: PharmacoEconomics 25 (2007) 11, pp. 913-933
ibandronate) are indicated for the treatment and prevention of osteoporosis but are costly compared with other treatments, such as … bisphosphonates for the prevention and treatment of osteoporosis in women aged >70 years, particularly if they have other risk factors …